News

Progress towards improved ACI, MACI cell therapies for cartilage damage

Mar 6, 2022

Spinning a solution in healthcare from a basic technology requires phased research from basic to translational, pre-clinical and clinical studies, for which Japan has a wholesome ecosystem; GN Corp track record, interviewed for a feature story, sponsored by Government of Japan, published in Bloomberg.

Please visit the article of Bloomberg.